Geneva, July 7 -- International Clinical Trials Registry received information related to the study (KCT0012166) titled 'A 12-week, randomized, double-blind, placebo-controlled clinical trial to evaluate efficacy and safety for improvement of SH_MRG on reduction of body fat' on June 24.
Study Type: Interventional Study
Study Design:
Primary Purpose : Supportive Care, Intervention Model : Parallel, Blinding/Masking : Double, Blinding Target : Subject, Investigator, Allocation : RCT
Primary Sponsor: Suheung
Condition:
Endocrine, nutritional and metabolic diseases
Intervention:
Dietary Supplement : Participants will be randomly assigned to either the test group or the control group and will consume either the test product or the co...